Health Canada RSS - Natural Health Products

sourse

Author: Health Canada

Changes made to List of Certain Non-prescription Drugs for Distribution as Samples (List D): Notice

The Natural and Non-prescription Drugs Directorate (NNHPD) has amended List D: List of certain non-prescription drugs for distribution as samples....

Read in sourse

Changes made to list of non-prescription drugs: Notice of modification

The Regulatory Operations and Enforcement Branch has amended the List of non-prescription drugs for which the testing requirements set out in subsections C.02.019 (1) and (2) of the Food and Drug Regulations...

Read in sourse

Notice: Clinical trials for medical devices and drugs relating to COVID-19 regulations

Information on the regulations for clinical trials for medical devices and drugs relating to COVID-19 transition from the Interim Order....

Read in sourse

Notice of updated guidance: Applications for COVID-19 drug clinical trials under the Regulations

Health Canada has updated and renamed the guidance document that was created for the interim orders No. 1 and No. 2 for COVID-19-related clinical trials for drugs....

Read in sourse

Notice: Period reduced for keeping clinical trial records for drugs and natural health products

Information on Health Canada reducing the period for keeping clinical trial records for drugs and natural health products from 25 years to 15 years....

Read in sourse

Notice: Regulations amending certain regulations concerning drugs and medical devices (shortages)

The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were made on 03-02, 2022. They amend the Food and Drug Regulations and Medical Devices Regulations that were published on 09-01-2022. They extend and modify...

Read in sourse

What we heard report on the clinical trials regulatory modernization initiative

Health Canada has published a "What we heard" report summarizing the comments received during the consultation on our Clinical Trials Regulatory Modernization Initiative from May 20, 2021 to July 4, 2021....

Read in sourse

Guidance Document on the Distribution of Drugs as Samples

Health Canada is pleased to announce the Guidance Document – Distributing samples of prescription drugs, non-prescription drugs and natural health products...

Read in sourse

Stop illegal marketing of drugs and devices

Find out about the impacts of illegal marketing, illegal marketing techniques, how to file a marketing complaint, and how we handle the complaints we receive‎....

Read in sourse

Web Posting – New Form for Natural Health Product Licence Applications

The Natural and Non-prescription Health Products Directorate is pleased to announce the posting of the new web-based Natural Health Product Licence Application Form (web PLA form)....

Read in sourse

Natural and Non-prescription Health Products Directorate (NNHPD) June 1, 2018 – December 31, 2018 – Engagement and Priorities

The Natural and Non-prescription Health Products Directorate has posted an overview of anticipated priorities and engagement opportunities....

Read in sourse

Web Posting – New Form and Accompanying User Guide for Natural Health Product Licence Amendments and Notifications

The Natural and Non-prescription Health Products Directorate is pleased to announce the posting of the new Natural Health Product Licence Amendment and Notification Form (ANF) as well as its accompanying user guide...

Read in sourse

Natural Health Products Ingredients Database is experiencing technical difficulties

We are actively working on a solution and apologize for any inconvenience this may cause....

Read in sourse

Health Canada Launches Public Consultations on the Proposed Approach to the Regulation of Cannabis

The proposed approach builds on the extensive consultations conducted by the Task Force on Cannabis Legalization and Regulation and on Canada’s existing system of regulated production of cannabis for medical purposes and industrial hemp....

Read in sourse

The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.